Mor Research Applications Ltd.

Nano-retina, Inc.

Dov Weinberger

Yossi Gross

Yaakov Milstain

David Rigler

Rani Mendelewicz

Dorit Raz Prag

Matan Zehavi

Tami Livnat

Yael Nisgav

Use of activated protein C (APC) for treatment and prevention of ocular diseases, disorders or conditions associated with retinal leakage and CNV such as age-related macular degeneration, optionally in combined therapy with anti-angiogenesis, anti-inflammatory, immunosuppressive, and anti PDGF agent.

Compositions and methods for treatment of ocular diseases

A method is provided for implanting, in an eye, apparatus having an electrode array including stimulating electrodes shaped to define distal tips protruding from the array, a plurality of photosensors, and driving circuitry, configured to drive the electrodes to apply currents to the retina. The method includes removing a lens of the eye and a vitreous body of the eye, creating a corneoscleral incision and inserting the apparatus through the corneoscleral incision into a vitreous cavity of the eye. During the inserting, an orientation of the distal tips is maintained pointing towards a cornea of the eye. Subsequently to the inserting, the apparatus is rotated such that the distal tips point towards a macula of the eye. Subsequently to the rotating, the apparatus is positioned epi-retinally, such that the distal tips of the electrodes penetrate the retina. Other applications are also described.

Surgical techniques for implantation of a retinal implant

Growing community of inventors

Tel Aviv, Israel

Dov Weinberger